SG
The startup develops a biochemical procedure that transforms implant surfaces into a bone-identical interface, promoting early bone formation and anti-inflammatory activity. This technology accelerates the healing process, enabling patients to recover more quickly and achieve a pain-free life post-surgery.
Updated 3 months ago
Funding
$830K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a biochemical procedure that transforms implant surfaces into a bone-identical interface, promoting early bone formation and anti-inflammatory activity. This technology accelerates the healing process, enabling patients to recover more quickly and achieve a pain-free life post-surgery.